Administration of Donor-Derived Mesenchymal Stem Cells Can Prolong the Survival of Rat Cardiac Allograft

Transplantation Proceedings

Volumn 38, Issue 9, 2006, Pages 3046-3051

  Zhou, H P ^a   Yi, D H ^a   Yu, S Q ^a   Sun, G C ^a   Cui, Q ^a   Zhu, H L ^a   Liu, J C ^a   Zhang, J Z ^a   Wu, T J ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MEDIATED LYMPHOLYSIS; CONTROLLED STUDY; DONOR; DOWN REGULATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CELL CULTURE TECHNIQUES; DNA PRIMERS; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; LYMPHOCYTE CULTURE TEST, MIXED; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, INBRED F344; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750955071     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.002     Document Type: Article

References (27)

1. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult mesenchymal stem cells. Science 284 (1999) 143
2. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697
3. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93
4. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195
5. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92
6. Le Blanc K., Tammik L., Sundberg B., et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 (2003) 11
7. Majumdar M.K., Keane-Moore M., Buyaner D., et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10 (2003) 228
8. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838
9. Tse W.T., Pendleton J.D., Beyer W.M., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389
10. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439
11. Grinnemo K.H., Mansson A., Dellgren G., et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 127 (2004) 1293
12. Denton M.D., Magee C.C., and Sayegh M.H. Immunosuppressive strategies in transplantation. Lancet 353 (1999) 1083
13. Wang J.S., Shum-Tim D., Galipeau J., et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120 (2000) 999
14. Fandrich F., Zhu X., Schroder J., et al. Different in vivo tolerogenicity of MHC class I peptides. J Leukoc Biol 65 (1999) 16
15. Corry R.J., Winn H.J., and Russell P.S. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16 (1973) 343
16. Wekerle T., and Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 52 (2001) 353
17. Helg C., Chapuis B., Bolle J.F., et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 58 (1994) 1420
18. Fandrich F., Lin X., Chai G.X., et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8 (2002) 171
19. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42
20. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282
21. Devine S.M., Bartholomew A.M., Mahmud N., et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29 (2001) 244
22. Ferber I., Schonrich G., Schenkel J., et al. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263 (1994) 674
23. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science 248 (1990) 1349
24. Onodera K., Hancock W.W., Graser E., et al. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol 158 (1997) 1572
25. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815
26. Devine S.M., Cobbs C., Jennings M., et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101 (2003) 2999
27. Allers C., Sierralta W.D., Neubauer S., et al. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 78 (2004) 503